Raffaele Pulli

Prof. Raffaele Pulli


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2008 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RPRaffaele Pulli
Raffaele Pulli
WDWalter Dorigo
Walter Dorigo
Nicola TroisiNicola Troisi
Nicola Troisi
GPGiovanni Pratesi
Giovanni Pratesi
AIAlessandro Alessi Innocenti
Alessandro Alessi Innocenti
CPCarlo Pratesi
Carlo Pratesi

1 March 2006 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RPRaffaele Pulli
Raffaele Pulli
WDWalter Dorigo
Walter Dorigo
Nicola TroisiNicola Troisi
Nicola Troisi
AIAlessandro Alessi Innocenti
Alessandro Alessi Innocenti
GPGiovanni Pratesi
Giovanni Pratesi
CPCarlo Pratesi
Carlo Pratesi

1 April 2013 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
RPRaffaele Pulli
Raffaele Pulli
WDWalter Dorigo
Walter Dorigo
PCP. Castelli
P. Castelli
VDV. Dorrucci
V. Dorrucci
FFF. Ferilli
F. Ferilli
CPC. Pratesi
C. Pratesi

1 September 2000 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
TBTamara Brunelli
Tamara Brunelli
DPDomenico Prisco
Domenico Prisco
SFSandra Fedi
Sandra Fedi
ARAngela Rogolino
Angela Rogolino
AFAlessandro Farsi
Alessandro Farsi
GPGuglielmina Pepe
Guglielmina Pepe

12 January 2012 in Endocrine-Related Cancer
Verified
Journal Article
Open access
PDF file
VPValentina Piccini
Valentina Piccini
ERElena Rapizzi
Elena Rapizzi
ABalessandra bacca
alessandra bacca
GTGiuseppe Di Trapani
Giuseppe Di Trapani
RPRaffaele Pulli
Raffaele Pulli
MMMassimo Mannelli,
Massimo Mannelli,
Head and neck paragangliomas (HNPGLs) are neural crest-derived tumors. In comparison with paragangliomas located in the abdomen and the chest, which are generally catecholamine secreting (sPGLs) and sympathetic in origin, HNPGLs are, in fact, parasympathetic in origin and are generally nonsecreting. Overall, 79 consecutive patients with HNPGL were examined for mutations in SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, MAX, and TMEM127 genes by PCR/sequencing. According to a detailed family history (FH) and clinical, laboratory (including metanephrines), and instrumental examinations, patients were divided into three groups: a) patients with a positive FH for HNPGL (index cases only), b) patients with a negative FH and multiple HNPGLs (synchronous or metachronous) or HNPGL associated with an sPGL, and c) patients with negative FH and single HNPGL. The ten patients in group a) proved to be SDHD mutation carriers. The 16 patients in group b) proved to be SDHD mutation carriers. Among the 53 patients in group c), ten presented with germ-line mutations (three SDHB, three SDHD, two VHL, and two SDHAF2). An sPGL was found at diagnosis or followed up in five patients (6.3%), all were SDHD mutation carriers. No SDHC, SDHA, MAX, and TMEM127 mutations were found. In SDHD mutation carriers, none of the patients affected by HNPGL associated with sPGL presented missense mutations. In conclusion, a positive FH or the presence of multiple HNPGLs is a strong predictor for germ-line mutations, which are also present in 18.8% of patients carefully classified as sporadic. The most frequently mutated gene so far is SDHD but others, including SDHB, SDHAF2, and VHL, may also be affected.

1 November 2011 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
WDWalter Dorigo
Walter Dorigo
RPRaffaele Pulli
Raffaele Pulli
PCPatrizio Castelli
Patrizio Castelli
VDVittorio Dorrucci
Vittorio Dorrucci
FFFiore Ferilli
Fiore Ferilli
CPCarlo Pratesi
Carlo Pratesi